Tumor repolarization by an advanced liposomal drug delivery system provides a potent new approach for chemo-immunotherapy

Immunosuppressive cells in the tumor microenvironment allow cancer cells to escape immune recognition and support cancer progression and dissemination. To improve therapeutic efficacy, we designed a liposomal oxaliplatin formulation (PCL8-U75) that elicits cytotoxic effects toward both cancer and im...

Descripción completa

Detalles Bibliográficos
Autores principales: Ringgaard, L., Melander, F., Eliasen, R., Henriksen, J. R., Jølck, R. I., Engel, T. B., Bak, M., Fliedner, F. P., Kristensen, K., Elema, D. R., Kjaer, A., Hansen, A. E., Andresen, T. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473747/
https://www.ncbi.nlm.nih.gov/pubmed/32917608
http://dx.doi.org/10.1126/sciadv.aba5628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473747/
https://www.ncbi.nlm.nih.gov/pubmed/32917608
http://dx.doi.org/10.1126/sciadv.aba5628

Ejemplares similares